Jun Xue
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Curcumin's Biomedical Applications
Papers in
-
- Circular RNAs in diseases 4
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 1
- Co-authors
- Te Liu (2 shared papers)Yongyi Huang (2 shared papers)Wei Cui (1 shared paper)Jiulin Chen (1 shared paper)Chuan Chen (1 shared paper)Hao Xi (1 shared paper)Huiying Chi (1 shared paper)Tao Liu (1 shared paper)
- Journals
- Tumor Biology (1 paper)Biochemical Society Transactions (1 paper)Gene (1 paper)Biochemical Pharmacology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesUkraine
In The Last Decade
Jun Xue
12 papers receiving 464 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 273
- Molecular Medicine 32
- Molecular Biology 335
- Geriatrics and Gerontology 9
- Pharmacology 21
Countries citing papers authored by Jun Xue
This map shows the geographic impact of Jun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xue more than expected).
Fields of papers citing papers by Jun Xue
This network shows the impact of papers produced by Jun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xue. The network helps show where Jun Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 122 | |
| 2 | 2013 | 82 | |
| 3 | 2015 | 50 | |
| 4 | 2018 | 47 | |
| 5 | 2016 | 44 | |
| 6 | 2020 | 34 | |
| 7 | 2014 | 28 | |
| 8 | 2019 | 28 | |
| 9 | 2020 | 27 | |
| 10 | 2020 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2019 | 1 | |
| 13 | 2025 | 0 |
About Jun Xue
Jun Xue is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 13 papers that have together received 468 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Histone Deacetylase Inhibitors Research (3 papers), MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers), Ferroptosis and cancer prognosis (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (273 citations), Molecular Medicine (32 citations), Molecular Biology (335 citations), Geriatrics and Gerontology (9 citations) and Pharmacology (21 citations). Jun Xue has collaborated with scholars based in China, United States and Ukraine. Frequent co-authors include Te Liu, Yongyi Huang, Wei Cui, Jiulin Chen, Chuan Chen, Hao Xi, Huiying Chi, Tao Liu, Shan Zhong and Sheng Zhang. Their work appears in journals such as Tumor Biology, Biochemical Society Transactions, Gene, Biochemical Pharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.